The 7th International Congress on Neuropathic Pain (NeuPSIG 2019) is an international forum that provides the latest research and developments in understanding the mechanisms, assessment, prevention and treatment of neuropathic pain. This meeting is an excellent opportunity to network and strengthen scientific collaboration. We hope you will join us in this unique opportunity to meet researchers, clinicians, and others from a wide range of disciplines, countries and backgrounds, disseminating and learning about the latest developments in the field.
NEW THIS YEAR - Lunch is provided complimentary to all attendees in an effort to enhance your experience at Congress. You will not need to leave the meeting to find food and miss out on valuable networking time with your colleagues.
Positive and negative sensory symptoms are very common in nerve damage related to diabetes, one of the largest burden in public health worldwide. Patients with diabetes and neuropathy comprise a substantial proportion, even in those with only glucose intolerance, a “pre-diabetic” condition. Read more.
Sensory dysfunction and pain are the most common and intractable treatment-limiting factors, and among the most distressing symptoms of cancer patients receiving chemotherapy. Sensory disturbances in chemotherapy-induced peripheral neuropathy (CIPN) range from numbness (paresthesia) and unpleasant tingling (dysesthesia) to painful cramps, deep muscle aches, and spontaneous burning pain. Read more.